Strs Ohio Tango Therapeutics, Inc. Transaction History

Strs Ohio

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$7.51 - $12.88 $17,273 - $29,624	-2,300 Reduced 12.64%	15,900 $126,000
Q4 2023 Jan 30, 2024	SELL	$6.52 - $12.01 $37,164 - $68,457	-5,700 Reduced 23.85%	18,200 $180,000
Q3 2023 Oct 26, 2023	BUY	$2.93 - $11.26 $29,300 - $112,600	10,000 Added 71.94%	23,900 $269,000
Q2 2023 Jul 31, 2023	BUY	$2.67 - $4.7 $8,010 - $14,100	3,000 Added 27.52%	13,900 $46,000
Q1 2023 Aug 02, 2023	SELL	$3.76 - $8.06 $11,280 - $24,180	-3,000 Reduced 21.58%	10,900 $43,000
Q2 2022 Jul 25, 2022	BUY	$3.86 - $8.01 $42,074 - $87,309	10,900 New	10,900 $49,000

123

91.7M

3.1K

1.5K

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $275M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.